Clinical practice guidelines for the management of biliary tract cancers 2015: The 2nd English edition

Masaru Miyazaki, Hideyuki Yoshitomi, Shuichi Miyakawa, Katsuhiko Uesaka, Michiaki Unno, Itaru Endo, Takehiro Ota, Masayuki Ohtsuka, Hisafumi Kinoshita, Kazuaki Shimada, Hiroaki Shimizu, Masami Tabata, Kazuo Chijiiwa, Masato Nagino, Satoshi Hirano, Toshifumi Wakai, Keita Wada, Hiroyuki Iasayama, Takuji Okusaka, Toshio TsuyuguchiNaotaka Fujita, Junji Furuse, Kenji Yamao, Koji Murakami, Hideya Yamazaki, Hiroshi Kijima, Yasuni Nakanuma, Masahiro Yoshida, Tsukasa Takayashiki, Tadahiro Takada

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Background The Japanese Society of Hepato-Biliary-Pancreatic Surgery launched the clinical practice guidelines for the management of biliary tract and ampullary carcinomas in 2008. Novel treatment modalities and handling of clinical issues have been proposed after the publication. New approaches for editing clinical guidelines, such as the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, also have been introduced for better and clearer grading of recommendations. Methods Clinical questions (CQs) were proposed in seven topics. Recommendation, grade of recommendation and statement for each CQ were discussed and finalized by evidence-based approach. Recommendation was graded to grade 1 (strong) and 2 (weak) according to the concept of GRADE system. Results The 29 CQs covered seven topics: (1) prophylactic treatment, (2) diagnosis, (3) biliary drainage, (4) surgical treatment, (5) chemotherapy, (6) radiation therapy, and (7) pathology. In 27 CQs, 19 recommendations were rated strong and 11 recommendations weak. Each CQ included the statement of how the recommendation was graded. Conclusions This guideline provides recommendation for important clinical aspects based on evidence. Future collaboration with cancer registry will be a key for assessment of the guidelines and establishment of new evidence. Free full-text articles and a mobile application of this guideline are available via http://www.jshbps.jp/en/guideline/biliary-tract2.html.

Original languageEnglish
Pages (from-to)249-273
Number of pages25
JournalJournal of Hepato-Biliary-Pancreatic Sciences
Volume22
Issue number4
DOIs
Publication statusPublished - 2015 Apr 1

Fingerprint

Biliary Tract Neoplasms
Practice Management
Practice Guidelines
Guidelines
Mobile Applications
Biliary Tract
Registries
Publications
Drainage
Radiotherapy
Therapeutics
Pathology
Carcinoma
Drug Therapy
Neoplasms

Keywords

  • Ampullary carcinoma
  • Bile duct carcinoma
  • Biliary tract cancer
  • Gallbladder carcinoma

ASJC Scopus subject areas

  • Hepatology
  • Surgery

Cite this

Clinical practice guidelines for the management of biliary tract cancers 2015 : The 2nd English edition. / Miyazaki, Masaru; Yoshitomi, Hideyuki; Miyakawa, Shuichi; Uesaka, Katsuhiko; Unno, Michiaki; Endo, Itaru; Ota, Takehiro; Ohtsuka, Masayuki; Kinoshita, Hisafumi; Shimada, Kazuaki; Shimizu, Hiroaki; Tabata, Masami; Chijiiwa, Kazuo; Nagino, Masato; Hirano, Satoshi; Wakai, Toshifumi; Wada, Keita; Iasayama, Hiroyuki; Okusaka, Takuji; Tsuyuguchi, Toshio; Fujita, Naotaka; Furuse, Junji; Yamao, Kenji; Murakami, Koji; Yamazaki, Hideya; Kijima, Hiroshi; Nakanuma, Yasuni; Yoshida, Masahiro; Takayashiki, Tsukasa; Takada, Tadahiro.

In: Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 22, No. 4, 01.04.2015, p. 249-273.

Research output: Contribution to journalArticle

Miyazaki, M, Yoshitomi, H, Miyakawa, S, Uesaka, K, Unno, M, Endo, I, Ota, T, Ohtsuka, M, Kinoshita, H, Shimada, K, Shimizu, H, Tabata, M, Chijiiwa, K, Nagino, M, Hirano, S, Wakai, T, Wada, K, Iasayama, H, Okusaka, T, Tsuyuguchi, T, Fujita, N, Furuse, J, Yamao, K, Murakami, K, Yamazaki, H, Kijima, H, Nakanuma, Y, Yoshida, M, Takayashiki, T & Takada, T 2015, 'Clinical practice guidelines for the management of biliary tract cancers 2015: The 2nd English edition', Journal of Hepato-Biliary-Pancreatic Sciences, vol. 22, no. 4, pp. 249-273. https://doi.org/10.1002/jhbp.233
Miyazaki, Masaru ; Yoshitomi, Hideyuki ; Miyakawa, Shuichi ; Uesaka, Katsuhiko ; Unno, Michiaki ; Endo, Itaru ; Ota, Takehiro ; Ohtsuka, Masayuki ; Kinoshita, Hisafumi ; Shimada, Kazuaki ; Shimizu, Hiroaki ; Tabata, Masami ; Chijiiwa, Kazuo ; Nagino, Masato ; Hirano, Satoshi ; Wakai, Toshifumi ; Wada, Keita ; Iasayama, Hiroyuki ; Okusaka, Takuji ; Tsuyuguchi, Toshio ; Fujita, Naotaka ; Furuse, Junji ; Yamao, Kenji ; Murakami, Koji ; Yamazaki, Hideya ; Kijima, Hiroshi ; Nakanuma, Yasuni ; Yoshida, Masahiro ; Takayashiki, Tsukasa ; Takada, Tadahiro. / Clinical practice guidelines for the management of biliary tract cancers 2015 : The 2nd English edition. In: Journal of Hepato-Biliary-Pancreatic Sciences. 2015 ; Vol. 22, No. 4. pp. 249-273.
@article{edfba209b78b45cc8c0fbdafe37d66ed,
title = "Clinical practice guidelines for the management of biliary tract cancers 2015: The 2nd English edition",
abstract = "Background The Japanese Society of Hepato-Biliary-Pancreatic Surgery launched the clinical practice guidelines for the management of biliary tract and ampullary carcinomas in 2008. Novel treatment modalities and handling of clinical issues have been proposed after the publication. New approaches for editing clinical guidelines, such as the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, also have been introduced for better and clearer grading of recommendations. Methods Clinical questions (CQs) were proposed in seven topics. Recommendation, grade of recommendation and statement for each CQ were discussed and finalized by evidence-based approach. Recommendation was graded to grade 1 (strong) and 2 (weak) according to the concept of GRADE system. Results The 29 CQs covered seven topics: (1) prophylactic treatment, (2) diagnosis, (3) biliary drainage, (4) surgical treatment, (5) chemotherapy, (6) radiation therapy, and (7) pathology. In 27 CQs, 19 recommendations were rated strong and 11 recommendations weak. Each CQ included the statement of how the recommendation was graded. Conclusions This guideline provides recommendation for important clinical aspects based on evidence. Future collaboration with cancer registry will be a key for assessment of the guidelines and establishment of new evidence. Free full-text articles and a mobile application of this guideline are available via http://www.jshbps.jp/en/guideline/biliary-tract2.html.",
keywords = "Ampullary carcinoma, Bile duct carcinoma, Biliary tract cancer, Gallbladder carcinoma",
author = "Masaru Miyazaki and Hideyuki Yoshitomi and Shuichi Miyakawa and Katsuhiko Uesaka and Michiaki Unno and Itaru Endo and Takehiro Ota and Masayuki Ohtsuka and Hisafumi Kinoshita and Kazuaki Shimada and Hiroaki Shimizu and Masami Tabata and Kazuo Chijiiwa and Masato Nagino and Satoshi Hirano and Toshifumi Wakai and Keita Wada and Hiroyuki Iasayama and Takuji Okusaka and Toshio Tsuyuguchi and Naotaka Fujita and Junji Furuse and Kenji Yamao and Koji Murakami and Hideya Yamazaki and Hiroshi Kijima and Yasuni Nakanuma and Masahiro Yoshida and Tsukasa Takayashiki and Tadahiro Takada",
year = "2015",
month = "4",
day = "1",
doi = "10.1002/jhbp.233",
language = "English",
volume = "22",
pages = "249--273",
journal = "Journal of Hepato-Biliary-Pancreatic Sciences",
issn = "1868-6974",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Clinical practice guidelines for the management of biliary tract cancers 2015

T2 - The 2nd English edition

AU - Miyazaki, Masaru

AU - Yoshitomi, Hideyuki

AU - Miyakawa, Shuichi

AU - Uesaka, Katsuhiko

AU - Unno, Michiaki

AU - Endo, Itaru

AU - Ota, Takehiro

AU - Ohtsuka, Masayuki

AU - Kinoshita, Hisafumi

AU - Shimada, Kazuaki

AU - Shimizu, Hiroaki

AU - Tabata, Masami

AU - Chijiiwa, Kazuo

AU - Nagino, Masato

AU - Hirano, Satoshi

AU - Wakai, Toshifumi

AU - Wada, Keita

AU - Iasayama, Hiroyuki

AU - Okusaka, Takuji

AU - Tsuyuguchi, Toshio

AU - Fujita, Naotaka

AU - Furuse, Junji

AU - Yamao, Kenji

AU - Murakami, Koji

AU - Yamazaki, Hideya

AU - Kijima, Hiroshi

AU - Nakanuma, Yasuni

AU - Yoshida, Masahiro

AU - Takayashiki, Tsukasa

AU - Takada, Tadahiro

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Background The Japanese Society of Hepato-Biliary-Pancreatic Surgery launched the clinical practice guidelines for the management of biliary tract and ampullary carcinomas in 2008. Novel treatment modalities and handling of clinical issues have been proposed after the publication. New approaches for editing clinical guidelines, such as the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, also have been introduced for better and clearer grading of recommendations. Methods Clinical questions (CQs) were proposed in seven topics. Recommendation, grade of recommendation and statement for each CQ were discussed and finalized by evidence-based approach. Recommendation was graded to grade 1 (strong) and 2 (weak) according to the concept of GRADE system. Results The 29 CQs covered seven topics: (1) prophylactic treatment, (2) diagnosis, (3) biliary drainage, (4) surgical treatment, (5) chemotherapy, (6) radiation therapy, and (7) pathology. In 27 CQs, 19 recommendations were rated strong and 11 recommendations weak. Each CQ included the statement of how the recommendation was graded. Conclusions This guideline provides recommendation for important clinical aspects based on evidence. Future collaboration with cancer registry will be a key for assessment of the guidelines and establishment of new evidence. Free full-text articles and a mobile application of this guideline are available via http://www.jshbps.jp/en/guideline/biliary-tract2.html.

AB - Background The Japanese Society of Hepato-Biliary-Pancreatic Surgery launched the clinical practice guidelines for the management of biliary tract and ampullary carcinomas in 2008. Novel treatment modalities and handling of clinical issues have been proposed after the publication. New approaches for editing clinical guidelines, such as the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, also have been introduced for better and clearer grading of recommendations. Methods Clinical questions (CQs) were proposed in seven topics. Recommendation, grade of recommendation and statement for each CQ were discussed and finalized by evidence-based approach. Recommendation was graded to grade 1 (strong) and 2 (weak) according to the concept of GRADE system. Results The 29 CQs covered seven topics: (1) prophylactic treatment, (2) diagnosis, (3) biliary drainage, (4) surgical treatment, (5) chemotherapy, (6) radiation therapy, and (7) pathology. In 27 CQs, 19 recommendations were rated strong and 11 recommendations weak. Each CQ included the statement of how the recommendation was graded. Conclusions This guideline provides recommendation for important clinical aspects based on evidence. Future collaboration with cancer registry will be a key for assessment of the guidelines and establishment of new evidence. Free full-text articles and a mobile application of this guideline are available via http://www.jshbps.jp/en/guideline/biliary-tract2.html.

KW - Ampullary carcinoma

KW - Bile duct carcinoma

KW - Biliary tract cancer

KW - Gallbladder carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84925963050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925963050&partnerID=8YFLogxK

U2 - 10.1002/jhbp.233

DO - 10.1002/jhbp.233

M3 - Article

C2 - 25787274

AN - SCOPUS:84925963050

VL - 22

SP - 249

EP - 273

JO - Journal of Hepato-Biliary-Pancreatic Sciences

JF - Journal of Hepato-Biliary-Pancreatic Sciences

SN - 1868-6974

IS - 4

ER -